Image enhancement developer ContextVision is partnering with the Karolinska Institute to develop new medical imaging tools.
The partnership with the institute's division of clinical geriatrics at the department of neurobiology, care sciences, and society will focus on the development of diagnostic decision-support functions linked to MRI to help radiologists improve diagnosis for Alzheimer's disease and dementia, according to the company.
Partly funded by the Swedish government, the first project will focus on developing an accurate method for diagnosis and follow-up of Alzheimer's disease. It will be the first step toward evaluating the potential of a decision-support tool that is based on previous academic research performed at Karolinska Institute, ContextVision said.
